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Abstract
Intensive Outpatient programs for mental health and substance abuse have been shown to
be an effective option for individuals with substance use disorders. Despite this, there are few
options for individuals seeking this form of treatment in rural communities. It is often believed
that high quality programs that address the core systemic social issues that underlie substance use
disorders are too expensive for small rural healthcare organizations to utilize. This model shows
one treatment program that is able to address multiple social safety net issues and produce
positive outcomes in a rural setting by leveraging community partnerships, as well as discussing
future policy implications.
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CHAPTER I INTRODUCTION
1.1

Background and Need

The United States is currently in the throes of an opioid epidemic that has cost more than
half a million Americans their lives (CDC, 2020). Beginning in the late 1990s with the overprescribing of opioid medication, the epidemic has evolved to include newer, even more deadly
synthetic opioids. Hidden beneath the proliferation of opioid abuse deaths, stimulant abuse and
fatality rates are also on the rise after several consecutive years of decline due to an increase in
“polypharming” or polysubstance abuse. The cumulative effect of these increases has made drug
overdose the leading cause of injury related death in the United States, particularly in rural
communities (CDC, 2020).
The widespread destruction incurred as a result of the substance abuse epidemic has
generated staggering economic and societal losses ranging from rising healthcare costs,
overburdened criminal justice and child welfare systems, decline in active workforce
participation, as well as increase in substance abuse related morbidity and mortality (Crowley,
Connell, Jones, & Donovan, 2019). The National Survey on Drug Use and Health estimated that
12.5 million Americans had used prescription pain medicines for non-medicinal purposes in the
previous year (SAMHSA, 2014). The millions of individuals who meet the current DSM
(Diagnostic Standard Manual) criteria for substance use disorders accumulate great costs in
direct healthcare provision and, without proper treatment, have significantly reduced lifespans
and poorer health outcomes (SAMHSA, 2008).
The majority of the cost for the raging substance abuse epidemic is borne by public taxfunded services. In addition to the increasing costs of incarceration and social safety net systems,
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Medicaid is the primary payer source for individuals with mental health diagnosis (Medicaid,
2020). One study found that the total cost of healthcare per patient was 30% less for individuals
compliant with Opioid Use Disorder treatment than those who were not compliant (Ronquest,
Wilson, Montejano, Nadpipelli, & Wollschlaeger, 2018). Additionally, the cost related
substance-abuse related conditions such as HIV/ AIDs positive status, Viral Hepatitis C status,
and Neonatal Abstinence Syndrome (NAS) also incur billions of additional dollars annually in
healthcare spending (National Institute on Drug Abuse, 2020).
1.2

Problem Statement

Opioid use disorder is particularly prevalent in rural America where there exist fewer
opportunities for treatment. Additionally, OUD often results in multiple public organizations’
involvement including; healthcare, criminal courts, and prisons/jails. Thus, a collaborative
multimodal program including and aimed at treating OUD and its consequences in multiple
settings is needed.
1.3

Primary Aim and Research Hypotheses

The aim of this study is to examine if a small-scale, social work-based substance abuse
treatment programs run by rural healthcare organizations can be effective at reducing substance
abuse related fatality, increasing substance use treatment program completion, and decreasing
recidivism. We hypothesize that if a comprehensive, evidence-based, community and
collaboration-oriented treatment model is implemented in a rural community, then overdose
deaths will decrease, successful treatment completion will increase, and return to use will
decrease.
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1.4

Population

The population that will be examined in this study are recently incarcerated individuals
with non-violent substance abuse related offenses who demonstrate high risk of recidivism based
on mental health and substance abuse co-occurring diagnosis. In addition, patients of the same
criteria who may or may not have criminal offenses but are recognized by the civil court system
as having co-morbid mental health and substance abuse diagnosis are also included. The
participants are between the ages of 18-65. The program is non-gender specific and has male,
female, and non-binary participants comingled. No family members or close pre-existing
connections may exist for participation (important in a rural community). All participants live in
a single rural county in Indiana.
Participants may enter the program after being determined to meet the American Society
of Addiction Medicine (ASAM) criteria for intensive outpatient services. This screening is
provided by a licensed mental health practitioner that utilizes the ASAM’s criteria for
determining appropriate level of care. Patients who score too highly on the ASAM criteria are
referred to a higher level of care (Partial Hospitalization Programs or inpatient facilities).
Participants who score too low on the ASAM are admitted into an alternative treatment program
that provides less intensive services. If at any point during the program the participant’s level of
need changes, the participant was immediately removed from the program and redirected to the
appropriate level of care. In the event that a participant is removed from the program to be
transferred to psychiatric inpatient or residential treatment, all their associated data is removed
from the study and they are effectively considered removed from the program. If the participant
returns to the program after completing a psychiatric inpatient stay, then the data is restarted
from the new entry date and previous data remains excluded from the study.
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All participants are encouraged to make their own informed choices about Medication Assisted
Treatment (MAT) and all forms of MAT are accepted in the program, however only naltrexone
and buprenorphine are provided internally. No participants are excluded on the basis of MAT
status.
2

CHAPTER II SCOPING LITERATURE REVIEW

Many of the costs associated with the substance abuse epidemic are concentrated most
heavily in non-urban areas (Ziller, Anderson, & Coburn, 2010). For example, since 2009, the
largest demographic of viral hepatitis C positive patients are non-urban whites between the ages
of 20-30 (Stopka, et al., 2017). Lack of treatment options, insufficient social safety networks, and
failing infrastructure create unique and costly challenges for rural communities who consistently
have higher rates of opioid morbidity and mortality than their urban counterparts. For example, a
newborn who meets criteria for NAS can be expected to cost more than three times as much as a
healthy infant, spend 3.5 times as long in the hospital, and have higher 30-day readmission rates
than from any other cause (Patrick, et al., 2015). Consequently, in the state of West Virginia,
83% of the cost of this care is paid by taxpayer funded Medicaid programs, and the intensity of
care required by the infants further strains already collapsing rural obstetrics programs nationally
(Umer, et al., 2020).
The increased incidence of opioid overdose deaths is strongly correlated to a lack of
treatment providers in rural areas (Haffajee, Lin, Bohnert, & Goldstick, 2019). In 2016, 60% of
rural communities did not have a single MAT waivered provider who could prescribe
buprenorphine for the treatment of opioid use disorder (Jones, 2017). As of 2021, In Ripley
County, Indiana, a rural county of approximately 28,000 residents, there are only two Medication
Assisted Treatment providers (SAMHSA, 2021). Only one of the providers is actively utilizing
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MAT as part of their regular practice, despite the evidence that it improves treatment retention,
reduces risk of relapse, and lowers incidence rate of communicable diseases like HIV/AIDS and
Hepatitis C (Kresina & Lubran, 2011). In addition to a stark shortage of MAT providers, rural
communities also lag far behind urban communities in number of psychiatrists, psychiatric nurse
practitioners, and counselors. According to the Rural Health Research and Policy Center, 91% of
rural counties do not have a single psychiatric advanced practice provider, 80% do not have a
psychiatrist, and 24% do not have any licensed counselors (Larson, Patterson, Garberson, &
Andrilla, 2016). The result of this shortfall in healthcare providers is billions of dollars in
downstream macro and micro economic losses (Larson, Patterson, Garberson, & Andrilla, 2016).
Proliferation of the Substance Abuse Problems
In the midwestern state of Indiana, nearly one in every 12 Hoosiers meets the DSM
criteria for a substance abuse disorder (Casey & Greene, 2017). The number of overdose deaths
in Indiana have doubled since 2010, with a 600% increase in death due to synthetic opioids
(National Institute on Drug Abuse, 2020). Ripley County is a rural community of approximately
28,000 in southeastern Indiana. Like most other communities, Ripley County suffers from a lack
of mental health provider resources to meet the needs of the community. For comparison, Marion
County, Indiana, home to the state capital of Indianapolis (population of 876,862) has a ratio of
population to mental health providers equaling 350:1; Ripley County, on the other hand, has a
ratio of 1 provider for every 1,900 residents (Robert Wood Johnson Foundation, 2020).
In 2016, a rate of 27.73 individuals per 100,000 died of overdose in Ripley County, a
rate significantly higher than the 22.8 per 100,000 that Indiana averaged as a whole. Overdose
death rates were also higher for each type of drug, with opioid death rates being twice as high as
the state average (24.26 per 100,00 to 11.83 for the state) (ISDH, 2016). Additionally, 87% of
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the fatal overdoses in Ripley County contained an additional, unidentified substance indicating a
high rate of polysubstance abuse, as well as synthetic drug abuse (ISDH, 2016).
This data is further corroborated by data from the Indiana Department Division of Mental
Health and Addiction that shows 44.6% of substance abuse treatment episodes from patients in
Ripley County involved methamphetamine (compared to 36.5% for Indiana as a whole) (IPRC,
2019). Ripley County also has problematic scores on high risk traits, such as an elevated rate of
child abuse with nearly 1 out of every 4 children being a victim of abuse or neglect before their
18th birthday (IPRC, 2019). In correlation with these statistics, 73.5% of children removed from
their homes in Ripley County are due to parental substance abuse (IPRC, 2019).
Current Resource Map
According to the Substance Abuse and Mental Health Service Administration, there is
only one additional treatment facility in Ripley County (SAMHSA.gov, 2019). Community
Mental Health Center, located in Batesville, Indiana (more than 30 minutes from Versailles),
offers individual substance abuse treatment sessions. As of 2020, they do not currently provide
MAT in any form (though it is noted they will accept patients who receive medication
elsewhere). Additionally, there is limited psychiatric access through this facility. Margaret Mary
Health, both in collaboration with the Courts Addiction and Drug Services Program (CADS) and
general treatment programs, provides mental health and substance abuse treatment with 5
licensed providers across 3 locations (including Versailles). These services include outpatient
treatment, Intensive Outpatient Treatment, MAT, and psychiatric medications and consultations.
As of 2021, there are currently no Partial Hospitalization Programs (PHPs), no recovery
housing, no emergency shelters, no inpatient treatment options, and no inpatient substance
detoxification programs within either Ripley or neighboring Franklin Counties. Additionally,

12

there is only one Full Time Equivalent (FTE) psychiatrist servicing more than 65,000 patients.
There are also currently no options for adolescent substance abuse treatment.
Current Barriers to Treatment
Lack of Access
The stark lack of access to treatment providers creates long wait times and suboptimal
outcomes for patients with substance abuse and growing mental health needs nationwide. There
are currently over 115 million Americans living in a designated mental health provider shortage
area (Health Resources and Services Administration, 2020). While there is a national shortage of
mental health providers, the shortage of providers in Ripley County creates extensive wait times
for patients and exacerbates care completion rates for patient populations with acute stabilization
needs- such as those in recovery from substance abuse or in active substance use. A single
missed appointment could delay care for months as patients are reshuffled into prohibitive
provider waitlists.
Payment
While many patients qualify for Medicaid coverage through the state’s Affordable Care
Act insurance expansion, the barriers to application can be insurmountable. Currently state
issued identification, such as a driver’s license, must be produced, as well as a birth certificate
and proof of current employment (State of Indiana, 2021). In addition, some plans take several
months to mature their coverage to a full plan including mental health benefits, while some plans
routinely deny higher levels of care than office-based mental health services.
Despite these shortcomings, Medicaid is the number one payer for mental health services meaning that commercial insurer’s coverage of services is even more scattered, cumbersome, or
prohibitive to treatment (Shirk, 2008).
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Safety Net Services
Transportation
Lack of access to transportation in rural communities is a well-documented barrier to
treatment. Lack of providers and low population density areas leads to long travel distances
between each viable treatment center. Time spent in transit is a barrier, but rural communities
also have significantly fewer resources for individuals who do not have reliable modes of
transportation (Beardsley, Wish, Fitzelle, O'Grady, & Arria, 2003). In fact, transportation is so
critical to health outcomes that the Robert Wood Johnson Foundation published a brief in 2012
summarizing their research and declaring lack of access a social determinate of health (Robert
Wood Johnson Foundation, 2012). Another study found that the distance to treatment was not a
significant indication of whether or not a patient would remain engaged in outpatient substance
abuse and mental health services- instead, they found that access to free public transportation
proved to be the biggest factor (Whetten, Pence, Reif, Conover, & Bouis, 2006). However,
public transportation has ceased to exist, or has dramatically reduced, in most rural communities.
Decreases in population density due to declining birthrates and outmigration, as well as rising
fuel costs, has made maintaining public bus systems and taxi services unsustainable in most rural
communities (Federal Highway Administration , 2001). This lack of transportation infrastructure
has led to significant challenges in retention of participants in mental health services, as well as
subsequent reduction in workforce participation and worsening health outcomes.
Housing
Homelessness in rural America is difficult to define and even harder to study. There is a
significant gap in research in this area, and the research that exists often undercounts the severity
of the issue for several reasons. First, higher rates of transitional homelessness manifest
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differently than in urban communities. Often, individuals who experience this type of
homelessness are “doubled-up” with friends or relatives and are not able to readily identify
themselves as experiencing housing insecurity (HRSA, 2014). Additionally, rural homelessness
differs in its high rates of substandard housing and lack of access to government subsidized
alternatives. In 2012, the Housing Assistance Council released a report indicating that nearly 1.5
million rural American households were rated as either substandard or extremely substandardmany having no access to modern indoor plumbing (Housing Assistance Council , 2012).While
the general lack of public housing is already challenging in rural communities, state policies
limiting government subsidized alternatives for individuals with felony histories further
complicates housing insecurity for the recently incarcerated. Therefore, it serves as no surprise
that recently incarcerated individuals referred by the criminal and civil justice systems for mental
health evaluation face 40 times the rate of homelessness compared to the general population
(Broner, Lang, & Behler, 2009).
In 2009, a study was conducted on individuals who participated in a Mental Health Court
model to see if homelessness affected the rate of recidivism and completion of treatment for
individuals in the program (Broner, Lang, & Behler, 2009). Participants in the program were
followed for 12 months -post diversion and were provided with support, such as case
management services. The study included 500 individuals who were housed, and 89 individuals
who were homeless. The study found that homelessness status did not significantly predict
program graduation or re-arrest. However, housing instability was found to have significant
negative effects on outcomes, arrests, and non-graduation rates for both homeless and housed
individuals (Broner, Lang, & Behler, 2009).
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While it was found that housing instability, rather than homelessness, predicted poor
outcomes, there is a great discrepancy in the numbers of individuals studied. There are nearly
400 more individuals who were not classified as homeless. Additionally, there is limited clarity
on potential confounding factors between the two populations. The study postulates that the lack
of ability for homelessness to directly predict recidivism, despite its clear relationship, is due to
other factors. For example, patients who experience homelessness are less likely to be compliant
on medication regiments, and vice versa. Patients who are not compliant on psychiatric
medication regimens are significantly more likely to reoffend (Draine & Solomon, 1994). It is
important that the study connects these factors because each of them interdependently may have
more effect on a patient successfully completing a 12-month Mental Health Court model than
homelessness directly. However, in spite of the presence of potentially confounding
circumstances, the link between the recently incarcerated, homelessness, and poor outcomes is
clear. Additionally, the benefit of social services in addressing these issues to improve outcomes
was also demonstrated.
Food Insecurity
While rural America is often associated with images of sprawling farmland, rates of food
insecurity are second only to inner city metropolitan areas (Piontak & Schulman, 2014). Food
insecurity is primarily an issue of poverty and is highest among the unemployed, underemployed, and wage workers (Piontak & Schulman, 2014). This study by Piontak and Schulman
is especially salient due to its relationship with the recently incarcerated and criminally involved
populations, which are significantly more likely to experience employment challenges. An
additional longitudinal study on former prisoners similarly reported significant barrios among the
subjects to even meet the minimal needs for shelter and food and that long term economic
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stability was rarely accomplished(Harding, Wyse, Dobson, & Morenoff, 2014). Moreover,
another study in the state of Florida found a correlation between individuals who had higher rates
of food insecurity and the inability to manage chronic health conditions due to the added
financial burden of health-care costs (Bradley, Vitous, Walsh-Felz, & Himmelgreen, 2018).
Subsequently, individuals with substance abuse offenses and increased food insecurity were
significantly more likely to recidivate both for new substance abuse offenses as well as
additional petty crime such as theft (Tuttle, 2019).
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3
3.1

CHAPTER III METHODOLOGY

Research Design

This study will utilize a mixture of quantitative and descriptive data to describe the design
and evolution of a single rural treatment program, examine results and the collective impact, and
discuss policy changes and pertinent challenges. The descriptive cohort design was chosen for
the purposes of exploring the progression of the program over the two years included in the
study, including multiple revisions to curriculum and included services and the rationale for
these changes. The goal of this study is to provide practical application and focus, by developing
a comprehensive and replicatable blueprint for other communities to follow.
3.2

Aims and Hypotheses

We hypothesize that if a comprehensive, evidence-based, community and collaborationoriented treatment model is implemented in a rural community, then overdose deaths will
decrease, recidivism will decrease, and treatment success will increase.

3.3

Sample Selection

The sample included in this study is every participant from a single from from October 1,
2018 to March 1, 2020. Both male and female participants referred from the Department of
Children Services or from Community Corrections are included, as well as all ages between 1865 years of age. Participants were included if they met the criteria for Intensive Outpatient level
of care on the American Society of Addiction Medicine (ASAM) standardized assessment tool.
Exclusion criteria was limited to individuals who were transferred from the program to a higher
level of care due to acute and unactipated destabilization and who also did not return to the

18

program for step-down services, or individuals who did not meet ASAM criteria for Intensive
Outpatient treatment.
3.4

Instrumentation

Data for the program was collected from October 1, 2018 to March 1, 2020, via the
reporting function for Cerner within a single community medical center. The selection criteria
for defining therapy visit data included every appointment with the program provider. These
appointments were then sorted into subtypes by billing codes and appointment type (i.e.
individual therapy session 60 minutes or group psychotherapy minutes). Data pertaining to
positive urine drug screens was collected from Community Corrections reports. Participants who
entered the program from sources other than corrections may not have complete urine drug
screen data. Patients who were excluded due to transfer to inpatient or residential facilities were
manually removed from the dataset.
3.5

Data Set Description

Discrete data elements include study patient identifiers (de-identified) and demographics,
service type, age, insurance type, dates of service, number of visits and diagnosis codes. Further
data such as MATstatus was manually collected by providers so as to include data from outside
sources as well as internal reporting for prescriptions written by system providers. Graduation
rates were attained from patient discharge summaries. The status of minor children in the home
or pregnany status was self-reported and recorded during the psychosocial evaluation.
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Table 1: Data Dictionary

Data Element
Education status (last level of formal education

Source
Electronic Health Record

completed)

Data Type
Categorical
Data

Referral Source (Criminal Court, Civil Court, Self-

Electronic Health Record/

Categorical

Referral)

Recorded at Intake

Data

Sexual Orientation (Lesbian, Gay, Bisexual,

Electronic Health Record/

Categorical

Transexual, Questioning, Other)

Reported at Intake

Data

Race (Caucasian, Black, Latino, Asian, Native

Electronic Health Record/

Categorical

American, Pacific Islander, Other)

Reported at intake

Data

Gender (Male, Female, Non-Binary, Other)

Electronic Health

Categorical

Record/Reported as part of

Data

intake
Age (18-65)

Electronic Health

Continuous

Record/Age of participant
at initial intake
Number of Completed Psychotherapy Sessions

Electronic Health Record

including Individual Psychotherapy, Group

and billing records

Count Data

Psychotherapy, and Intensive Outpatient
Psychotherapy sessions)
Time in Treatment (months)

Electronic Health Record

Continous Data
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Number of Positive Weekly Urine Drug Screens

Probation Reports/

Count Data

During the Course of the Program

Electronic Health Record

Number of Mental Health Diagnoses During the

Electronic Health Record

Count Data

Electronic Health Record

Categorical

Course of the Program
Primary Payer Source (Medicaid or MCO,
Medicare,Commercial payer, Unisured)

Data

Dichotomous Indicators of social determinates (at

Self reported or recorded

Dichotomous

Program Start):

via Electronic Health

Data

-Homelessness

Record

-Food insecurity
-Domestic violence
Dichotomous Indicators for Comorbid Diseases:

3.6

Clinical psychiatric

Dichotomous
Data

-

Biopolar Disorder

assessment via the

-

Depression

Electronic Health Record

-

OCD

-

Anxiety

Data Collection/Procedure

Demographic information on the patients (age, gender, number of participants, LGBTQ+,
and referral source) will be retrieved from our Electronic Health Record (EHR) system utilizing
standard system reporting. Urine drug screen data is retrieved both from probation records as
well as the EHR system. Education status, employment status, food insecurity, and housing
insecurity are all self-reported. Psychiatric compliance, diagnosis codes, and MAT status were
also pulled from the participant medical record. During the course of the study, the group
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treatment rogram was held Mondays, Wednesdays, and Fridays from 5:00pm-8:00pm. Urine
drug screens were performed prior to group session. Unannounced home visits were conducted
by probation and DCS agents throughout the week where additional urine drug screens and
saliva screens were performed. Blood analysis for substances were conducted as part of routine
psychiatric care. Hair follicile screens were performed at random. Breathalizer screens were
given daily, sometimes multiple times per day, per judges order for individuals whose substance
of choice was alcohol only. Individual therapy sessions were conducted 1-2x per week and were
booked around the patient’s schedule. Case management, peer support, and wraparound services
were conducted on an as-needed basis, encompassing both normal clinic hours and weekend and
afterhours.
Data collected on patient demographic information, MAT status, medical and psychiatric
history, length of treatment, and insurance status were all collected from the intake, during the
course of treatment, and from the patient medical record. Information from outside sources, such
as referral source (criminal or civil court referral) and urine drug screens, was also utilized from
regular case staffing and reporting from community corrections and the Department of Child
Services. Participants in the program were considered “successfully completed” based on
extended period of abstinence, participation in treatment sessions, progress towards treatment
plan goals, and a decrease in overall clinical acuity allowing for transition to low intensity
outpatient services or peer support services. Discharge criteria included participation in 6 weeks
of peer support and continued absitinence even with decreased services. For all treatment
services, abstinence was defined as non-positive oberserved 10 and 12 panel urine drug screens
with laboratory verification, non-positive and timely breathalizer tests, and non-positive hair and
blood analysis screens. Completing all phases of the program and experiencing a decrease in
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acuity indicating the appropriateness of a lower level of treatment services was the criteria for
successful completion.

3.7

Protection of Human Subjects

Study is exempt from IRB review due to its status as a quality improvement study that
does not involve patient identifiers.
3.8

Statistical Analysis Methods

Descriptive statistics of the study cohort will be reported as count and frequencies for
categorical data, and mean, standard deviations, and range for continuous measures.
The hypothesis of opioid overdose death, recidivism, and treatment adherence (any return
to use) will be tested against average rates reported in the literature. Tests of binomial
proportions will be used to compare program rates to general rates. Opoid overdose death rates
within the program time period will be compared with the CDC reported rate of 22 deaths per
100,000 population in rural communities as a whole, as well as the gender-specific rates of 29.9
per 100,000 for males and 15.5 per 100,000 for females (CDC, 2019). Recidivism rate from the
program will be compared to population recidivism of 70% in substance users on probation
without access to cognitive behavioral therapies (Deitch, Koutsenok, & Ruiz, 2000). Treatment
success during the program will be compared with a population 6-month program success rate of
33% (Fishman & Reynolds, 1999)
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4.1

CHAPTER IV RESULTS or JOURNAL MANUSCRIPT

Results/Findings

Description of Program, Timing, and Changes Made
On October 1st, 2018, the program began as an intensive outpatient dual diagnosis
treatment program. The group sessions ran Monday, Wednesday, and Friday from 5:00pm8:00pm. Shortly after the program began, the acuity of the patients made additional individual
trauma processing therapy sessions necessary. Additionally, the large demand for services led to
the utilization of peer coaches to help manage the treatment sessions that occasionally held as
many as 12 participants. The participants were accepted to the program on a rolling basis. As a
spot came open, it was immediately filled. Graduation was predicated on progress and reduction
of symptoms, so the program length varied by severity of illness and participant’s individual
progress.
Within a week of the program’s inception on October 1st 2018, it became apparent that
many of the individuals participating were struggling with various levels of food insecurity.
Many individuals conveyed that they had very limited or no access to fresh foods, while a subset
of the original group indicating having limited or inconsistent access to food generally. We first
began to address this by distributing healthy box lunches that were made by the hospital cafeteria
for providers during treatment sessions. Program staff also purchased food items to send home
with patients during this time. However, neither of these approaches were sustainable long term.
By the fall of 2019, the program had partnered with the state of Indiana to implement Cooking
Matters curriculum. This curriculum is a teaching course designed to educate low-income
participants on nutrition and how to acquire fresh food at low prices. It also comes with grant
funding that allowed the purchase of basic cooking equipment and weekly fresh groceries,
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virtually eliminating food insecurity for participants who routinely showed up for services.
Transportation was also identified as a significant barrier. Many individuals who are
charged with substance abuse related crimes have their driving privileges revoked. In rural
Indiana, there is no public transportation system- no buses, cabs, or subways, etc. While there is
a local transportation service that provides discounted rides to individuals with Medicaid, the
costs of utilizing this program for the entire duration of treatment was extensive. In the summer
of 2019, the program sought out and received outside grant funding to help offset costs of
utilizing the transportation services for program participants. Individuals engaged in the program
were given tokens that represented their number of treatment sessions for the week to aid in
transportation. One shortcoming of this model is that the tokens did not cover other essential
transportation services- like transportation to the grocery store or dentist.
Housing continues to be a barrier to treatment within the program. Many participants are
forced to return back to unhealthy environments during the course of treatment due to lack of
affordable housing options. Currently, Ripley County has no emergency shelters. The domestic
violence shelter located within the county has been an excellent partner, but they took experience
more demand than they can meet given their current resources. This can make it very challenging
to find affordable, safe, and substance free housing for participants in the program and likely
decreases success overall.
In the future, the program is exploring the idea of procuring grant funding to allow
participants to have an electronic device that is secured in order to better facilitate hybrid
treatment models. These online and in-person combination programs have become a necessity
during the COVID-19 outbreak, but have also helped to mitigate challenges regarding
transportation and childcare for participants.
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Descriptive Statistics of Study Cohort
The aim of the study was to examine whether or not implementing a collaborative
substance abuse and mental health treatment program in a rural community would increase
overall treatment success and compliance, significantly reduce overdose deaths, and decrease
return to use. Of the 51 particiants included in the study, 34 or 66.67% successfully completed
the program with only 33% of that same number experiencing failure to complete. Participants
were considered successful if the ASAM criteria (indicated below) showed a reduction in
clinically appropriate level of treatment from Intensive Outpatient to Outpatient.
Table 2: ASAM Criteria (The American Society of Addiction Medicine, 2021)

Levels of Care
Criteria

Outpatient

Intensive
Outpatient

Intoxification/
Withdrawal
Medical
Complications

No risk

Minimal

No risk

Manageable

Psychiatric
Complications

No risk

Readiness for
Change

Cooperative

Relapse
Potential

Sustained
period of
abstinence

Mild severity,
manageable
with patient
cooperation
Cooperative
but requires
structure
Needs close
monitoring

Recovery
Environment

Supportive
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Medical
Monitoring
(some medical
management/
residential
treatment)
Moderate risk

Medical Management
(24 hour medical
observation/inpatient)

Some medical
risk-requires
monitoring
Some
psychiatric
risk- requires
monitoring
Moderate to
high resistance
to change
Unable to
control return
to use outside
of structured
environment
No capacity for
outpatient

24-hour acute medical
care required

Severe risk

24-hour psychiatric
monitoring required

Chi square tests were utilized to assess whether different descriptive variables had a
higher correlation to the successful completion of our program. The only variable that had a
significant P-value was whether or not the patient experienced multiple returns to use during the
program on successful completion (P < .0011). Of the 31 participants who successfully
completed the treatment, 65% (22/34) did not experience a return to use, 35% (12/34)
experienced a single return to use, and 0% had more than one return to use. For the participants
who did not successfully complete treatment, 41% did not experience a return to use, 24%
experienced one return to use, and 35% experienced multiple returns to use. Age and gender did
not significantly play a role in whether a patient was successful in the program. Patients who
were referred by the Criminal Court had a higher rate of completion that those referred by the
Civil Court (odds ratio was 2.13). Patients who also had access to psychiatric treatment and was
compliant with the treatment regimen led to a higher successful completion rate of the program
(odds ratio was 3.13).
The total sample for the study was 51 individuals who were seen as part of the dual
diagnosis program between October 1st 2018- March 1st, 2020. The gender distribution was
roughly equal with slightly more males than females (51% verses 49%). 31% of the participants
engaged in the program were reincarcerated or recidivated. 66% of the participants successfully
completed an average of 6.17 months (SD 3.7) of treatment and were released upon decrease of
clinical acuity as described by the ASAM criteria, representing an average of 31 completed
treatment sessions (SD 19.85).
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Table 3. Descriptive Statistics of Cohort

Non-Successful
Completion
(N=17)
N
%

Total

Variable

Successful
Completion
(N=34)
N
%

(N=51)
N

%

Age
18-25
26-33
34-42
43-50
50+

4
16
8
3
3

4
9
3
1
0

8
25
11
4
3

15%
49%
22%
8%
6%

Gender
Male
Female
Social
Determinants of
Health
Housing Insecurity
Food Insecurity
Domestic Violence
Pregnancy Status
Pregnant
Non-pregnant
Parent of Minor
Children
Participant has
Minor Children
Participant does not
have Minor
Children
Referral Source
Criminal Court
Civil Court

p
value
0.597

12%
47%
24%
9%
9%

24%
53%
18%
5%
0%

0.322
19
15

44%
53%

7
10

41%
59%

26
25

51%
49%
0.91

9
7
8

26%
21%
24%

4
4
5

24%
24%
29%

13
11
13

25%
21%
25%
0.77

5
29

15%
85%

2
15

12%
88%

7
44

14%
86%
0.32

13

38%

9

53%

22

43%

21

62%

8

47%

29

57%

30
4

88%
13%

16
1

94%
6%

46
5

90%
10%

0.50
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Payer Source
Medicaid
Medicare
Commercial
Uninsured/ Self-Pay
Psychiatric
Treatment History
Had Access to
Psychiatric
Treatment
Was Compliant
with Psychiatric
Treatment
Utilized MAT
Comorbid
Conditions
Dual Diagnosis
Bipolar Disorder
(Types 1 and 2)
Major Depressive
Disorder
General Anxiety
and/or Panic
Disorders
Obsessive
Compulsive
Disorder
ADHD/ADD
Trauma History
Documented
History of Physical,
Emotional, or
Sexual Abuse
Post-Traumatic
Stress Disorder
Return to Use
Did not Experience
Return to Use
During Program

0.44
30
1
2
1

88%
3%
6%
3%

17
0
0
0

100%
0%
0%
0%

47
1
2
1

92%
2%
4%
2%
0.68

15

44%

5

29%

20

39%

12

35%

2

12%

14

27%

14

41%

5

29%

19

37%
0.42

33
10

97%
29%

16
1

94%
6%

49
11

96%
21%

15

44%

3

18%

18

35%

17

50%

3

18%

20

39%

3

9%

1

6%

4

8%

8

24%

2

12%

10

20%
0.79

28

82%

10

59%

38

26

76%

8

47%

34

67%

0.0011
22

65%

7

41%

29

29

57%

Experienced a
Single Return to
Use
Experienced More
than 1 Return to
Use

12

35%

4

24%

16

31%

0

0%

6

35%

6

12%

Outcomes
Recidivism
Overdose Fatality
Program Successful
Completion

31%
0
66%

Table 4

Mean

Standard Deviation

Age of Participant

33.08 years

9.20 years

Length of Treatment
(Months)
Number of Completed
Treatment Sessions

6.17 months

3.70 months

31 sessions

19.85 sessions
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Recidivism
Of the 46 participants who were referred to the program from criminal courts, 16 returned
to jail or prison within the 6-month treatment perior (34.78%). When compared to population
recidivism of untreated individuals (70%), the program had a statistically small return to jail or
prison (95% CI 21.35% to 50.25%, p<0.0001).
Program Successful Completion
The program resulted in 66% of participants successfully completing 6 months of
treatment. When comparing this rate to the comparative published study rate of 33% (REF), we
found the program had a third higher success rate, resulting in a statistically significant success
rate (95% CI 51.39% to 78.68%, p<0.0001).
Death from Overdose
Finally, 0 patients experienced an overdose during the course of treatment, regardless of
successful program completion. The CDC reported rate of 22 deaths per 100,000 population in
rural communities as a whole, as well as the gender-specific rates of 29.9 per 100,000 for males
and 15.5 per 100,000 for females (CDC, 2019).Therefore, the expected overdose rate would be
roughly 6.16 for Ripley county. However, as previously mentioned, 0 individuals experienced an
overdose death during the data collection period of 8/1/2018-3/1/2020.

5
5.1

CHAPTER V DISCUSSION

Discussion of Results
As previously stated, the program was statistically very successful verses broader rural

benchmarks for similar services, even though indiviuals enrolled in the program were very high
acuity based off substance of choice, path of usage, and comorbidities. One significant difference
is how this program approaches treatment, providing incredibly intensive services as well as
wraparound services to address systemic issues such as housing insecurity, food insecurity,
domestic violence, and intensive trauma treatment approaches. Considering Medicaid was the
primary payer and has notoriously low rates compared to commercial payers, this level of service
was only made possibly by leveraging community partners and working very closely with
criminal justice and DCS representatives.
Another interesting data trend is that participants who completed the program
successfully reported higher levels of every comorbid mental illness in which data was collected,
as well as higher rates of trauma and trauma response. While on this surface this seems
counterintuitive, it may indicate that underreporting symptoms is a factor for repreated relapse
and non-completion of the program-particularly given that participants often were required to
complete the program as a condition of probation or restoration of parental rights. It could also
be indicative of the pre-contemplative stage of recovery, or a decrease in readiness to change.

5.2

Limitations
One significant limitation on this study is that all data was collected from a growing and

evolving program. During the course of the study, no two cohorts of participants ever had the
exact same experience. Upon the program’s inception, for example, food insecurity was
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identified as a significant barrier to treatment success. Therefore, food give-aways were
implemented during the second cohort of patients that may have skewed the food insecurity data
as time went on.
Another significant limitation is the small sample size that made it difficult to observe the
relationships between independent data points or understand them as part of a larger trend. More
longitudinal data should help clarify if relationships visible in the data sustain when the numbers
are larger or if they are merely a function of coincidence and small sample size.
5.3

Future Research
In many ways, this study is an introductory look at a novel program design that leverages

existing community resources to provide a low-cost and high-success program in a rural
community. As such, the data sparks more questions than it can answer and there is many
opportunities for further, more refined studies that drill down on various subparts of this study.
For example, the relationship of PTSD, child abuse, and cooccurring substance abuse and mental
health conditions. Additionally, other questions related to historically understudied populations
like the rural LGBTQ+ and their relationship with trauma and substance use. Last but not least,
the effects of poverty underscore many of the barriers facing those in substance abuse treatment,
and, in absence of those barriers, appears to reduce returns to use and recidivism- a point which
has significant implications for policymakers and social safety net programs alike. Further
examination of the specific relationship of the absence of food insecurity, housing insecurity, and
transportation on program completion, as well as how the reduction of each of those variables
predicted successful program completion, is also worthwhile.
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5.4

Conclusions
The overarching conclusion is that a small rural program, with help from community

partners, can be successful at curbing substance use and substance use-related deaths. This study
could be used to inform communities that are interested in increasing the number of substance
abuse services in a meaningful, yet affordable way. It could also be used by policymakers to
reimagine the way substance use programs in small communities are reimbursed, incentivizing
trauma-informed programs and overcoming community silos to improve outcomes and resource
utilization efficiency.
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